The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias-Reference-Cited by-同舟云学术

The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias

Published:2008-07-11 Issue:11 Volume:15 Page:1712-1722
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Kamitsuji Y,Kuroda J,Kimura S,Toyokuni S,Watanabe K,Ashihara E,Tanaka H,Yui Y,Watanabe M,Matsubara H,Mizushima Y,Hiraumi Y,Kawata E,Yoshikawa T,Maekawa T,Nakahata T,Adachi S

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/cdd2008107.pdf

Reference40 articles.

1. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996; 2: 561–566.

2. Melo JV, Deininger MW . Biology of chronic myelogenous leukemia – signaling pathways of initiation and transformation. Hematol Oncol Clin North Am 2004; 18: 545–568, vii–viii.

3. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001; 344: 1038–1042.

4. Kimura S, Ashihara E, Maekawa T . New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. Curr Pharm Biotechnol 2006; 7: 371–379.

5. Kuroda J, Puthalakath H, Cragg MS, Kelly PN, Bouillet P, Huang DC et al. Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Proc Natl Acad Sci USA 2006; 103: 14907–14912.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy targeted nanomedicines and nanotheranostics in cancer imaging and therapy;Journal of Drug Delivery Science and Technology;2024-09

2. Interaction of chloroquine with 2-(hydroxypropyl)-β-cyclodextrin through the supramolecular assembly for cytotoxicity on breast cancer cell lines;Monatshefte für Chemie - Chemical Monthly;2022-09-27

3. Tyrosine kinase inhibitors trigger lysosomal damage-associated cell lysis to activate the NLRP3 inflammasome;2022-02-19

4. Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy;Cancer Treatment and Research Communications;2022

5. Dependence of Viscosity and Diffusion on β-Cyclodextrin and Chloroquine Diphosphate Interactions;Processes;2021-08-19